Dow Up 0.11% Nasdaq Up 0.50%

Northwest Biotherapeutics, Inc. (NWBO)

-NasdaqCM
5.84 Down 0.03(0.51%) Aug 29, 4:00PM EDT
|After Hours : 5.79 Down 0.05 (0.86%) Aug 29, 7:45PM EDT
Prev Close:5.87
Open:5.96
Bid:5.79 x 2700
Ask:6.00 x 1500
1y Target Est:5.00
Beta:2.85
Next Earnings Date:N/A
Day's Range:5.79 - 5.98
52wk Range:3.10 - 10.64
Volume:321,978
Avg Vol (3m):1,011,070
Market Cap:347.50M
P/E (ttm):N/A
EPS (ttm):-2.48
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NWBO

Comparison

Symbol% ChgMkt Cap
NWBODown 0.51%347.50M
AGENDown 0.32%196.81M
DNDN 0.00%211.38M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):873.22
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :N/A
Quarterly EPS Est (Jun-14) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Northwest Biotherapeutics, Inc., a development stage biotechnology company, discovers and develops immunotherapy products to treat cancers in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback